financetom
Business
financetom
/
Business
/
REX Financial launches covered call Nvidia ETF hours before earnings release
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
REX Financial launches covered call Nvidia ETF hours before earnings release
May 28, 2025 3:10 PM

(Reuters) -REX Financial launched a single-stock exchange-traded fund tied to Nvidia ( NVDA ), the powerhouse chipmaker that has dominated stock market returns over the last two years, on Wednesday morning, hours ahead of the release of Nvidia's ( NVDA ) earnings.

The new fund, the REX NVDA Growth & Income ETF is a form of covered call ETF that uses option strategies to generate income while at the same time giving investors exposure to a portion of the upside in Nvidia's ( NVDA ) stock price, REX said.

"We think it will allow people to have their cake and eat it, too," said Scott Acheychek, REX's chief operating officer.

"They can stick with the stock that they follow and know and like, but with a risk profile that they're comfortable with and some weekly income" from the sale of options on Nvidia ( NVDA ), he said.

These single-stock option-based ETFs made their debut in late 2023, and now have about $10 billion in total assets. Overall interest in single-stock ETFs, a broader category that includes 1.5x or 2x leveraged products, continues to grow, said Bryan Armour, ETF analyst at Morningstar.

"They're all aimed at self-directed individual investors," Armour said.

While an ETF with this kind of structure likely would outperform the underlying stock if that stock is flat to lower, Armour said it makes more sense for investors either to buy individual stocks outright or to turn to options-based ETF strategies that are tied to broader portfolios.

"A product like this is not trying to maximize either growth or income."

Acheychek said this new approach to covered call single-stock ETFs is aimed at investors who increasingly are looking for alternative income-generating products.

Nvidia ( NVDA ) shares closed at $134.81 a share, down 0.5%, in exchange trading on Wednesday, ahead of the AI chipmaker's earnings announcement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Supreme Court rejects bid by oil companies to toss Honolulu's climate suit
US Supreme Court rejects bid by oil companies to toss Honolulu's climate suit
Jan 13, 2025
* Honolulu accuses oil firms of misleading public * Honolulu among various U.S. jurisdictions to sue oil firms By John Kruzel WASHINGTON, Jan 13 (Reuters) - The U.S. Supreme Court declined on Monday to hear a bid by Sunoco ( SUN ) and other oil companies to scuttle a lawsuit by Honolulu accusing them of misleading the public for decades...
US Supreme Court rejects bid by oil companies/Shell to toss Honolulu's climate suit
US Supreme Court rejects bid by oil companies/Shell to toss Honolulu's climate suit
Jan 13, 2025
WASHINGTON, Jan 13 (Reuters) - The U.S. Supreme Court declined on Monday to hear a bid by Sunoco ( SUN ) and other oil companies to scuttle a lawsuit by Honolulu accusing them of misleading the public for decades about the dangers of climate change induced by the burning of fossils fuels. The justices turned away an appeal by the...
Goldman Sachs creates new team to boost focus on financing
Goldman Sachs creates new team to boost focus on financing
Jan 13, 2025
Jan 13 (Reuters) - Goldman Sachs ( GS ) is creating a new team that will enhance its focus on financing mega deals and providing loans to corporate clients, as the Wall Street giant looks to grab a bigger slice of the lucrative private credit market. The new division, called Capital Solutions Group, will be a part of the investment...
Rigel Pharmaceuticals Expects Higher Q4 Revenue, Provides 2025 Revenue Guidance
Rigel Pharmaceuticals Expects Higher Q4 Revenue, Provides 2025 Revenue Guidance
Jan 13, 2025
09:38 AM EST, 01/13/2025 (MT Newswires) -- Rigel Pharmaceuticals ( RIGL ) said Monday it expects Q4 total revenue of $57.6 million, up from $35.8 million a year earlier. Analysts polled by FactSet expect $47.4 million. The company also said it expects 2025 total revenue of about $200 million to $210 million. Analysts surveyed by FactSet expect $193.5 million. Rigel...
Copyright 2023-2026 - www.financetom.com All Rights Reserved